Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
154 hedge funds and large institutions have $468M invested in Sucampo Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 47 increasing their positions, 56 reducing their positions, and 13 closing their positions.
192% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 13
37% more capital invested
Capital invested by funds: $341M → $468M (+$127M)
18% more funds holding
Funds holding: 130 → 154 (+24)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 56
30% less call options, than puts
Call options by funds: $1.75M | Put options by funds: $2.49M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$26.7M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$20.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.8M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$9.32M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$14.5M |
| 2 |
KAM
Krensavage Asset Management
New York
|
-$10.1M |
| 3 |
Daiwa Securities Group
Tokyo,
Japan
|
-$7.61M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$7.39M |
| 5 |
Millennium Management
New York
|
-$6.43M |
SCMP Hedge Fund Activity: Q3 2015 in Review
154 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q3 2015, worth a combined $468M — up 37% from $341M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new SCMP positions and 13 closed out — a net gain of 25 holders — while 47 added to existing stakes and 56 trimmed.
The largest buyer was State Street, adding an estimated $26.7M. The largest seller was Numeric Investors, cutting an estimated $14.5M.
- 154 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q3 2015, up from 130 in Q2 2015.
- Funds reported $468M of Sucampo Pharmaceuticals, Inc. stock for Q3 2015, up 37% quarter-over-quarter.
- 38 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q3 2015 and 13 closed out, a net change of +25 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q3 2015 was State Street, an estimated $26.7M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q3 2015 was Numeric Investors, an estimated $14.5M sold.
Based on aggregated 13F filings for Q3 2015.